BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kostas A, Siakavellas SI, Kosmidis C, Takou A, Nikou J, Maropoulos G, Vlachogiannakos J, Papatheodoridis GV, Papaconstantinou I, Bamias G. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease. World J Gastroenterol 2017; 23(41): 7387-7396 [PMID: 29151692 DOI: 10.3748/wjg.v23.i41.7387]
URL: https://www.wjgnet.com/1007-9327/full/v23/i41/7387.htm
Number Citing Articles
1
A Swaminathan, G M Borichevsky, T S Edwards, E Hirschfeld, T C Mules, C M Frampton, A S Day, M B Hampton, A J Kettle, R B Gearry. Faecal Myeloperoxidase as a Biomarker of Endoscopic Activity in Inflammatory Bowel DiseaseJournal of Crohn's and Colitis 2022;  doi: 10.1093/ecco-jcc/jjac098
2
Changchang Ge, Yi Lu, Hong Shen, Lei Zhu. Monitoring of intestinal inflammation and prediction of recurrence in ulcerative colitisScandinavian Journal of Gastroenterology 2022; 57(5): 513 doi: 10.1080/00365521.2021.2022193
3
Xue Guo, Chen Huang, Jing Xu, Haoming Xu, Le Liu, Hailan Zhao, Jiaqi Wang, Wenqi Huang, Wu Peng, Ye Chen, Yuqiang Nie, Yongjian Zhou, Youlian Zhou. Gut Microbiota Is a Potential Biomarker in Inflammatory Bowel DiseaseFrontiers in Nutrition 2022; 8 doi: 10.3389/fnut.2021.818902
4
Shin Young Park. Age-Related Fecal Calprotectin Concentrations in Healthy AdultsThe Korean Journal of Clinical Laboratory Science 2020; 52(3): 181 doi: 10.15324/kjcls.2020.52.3.181
5
Ryan Ungaro, Jean-Frédéric Colombel, Trevor Lissoos, Laurent Peyrin-Biroulet. A Treat-to-Target Update in Ulcerative Colitis: A Systematic ReviewAmerican Journal of Gastroenterology 2019; 114(6): 874 doi: 10.14309/ajg.0000000000000183
6
Paulina Nuñez F, Uma Mahadevan, Rodrigo Quera, Constanza Bay, Patricio Ibañez. Treat-to-target approach in the management of inflammatory Bowel diseaseGastroenterología y Hepatología (English Edition) 2021; 44(4): 312 doi: 10.1016/j.gastre.2020.06.023
7
Adam Makaro, Łukasz Dziki, Jakub Fichna, Marcin Włodarczyk. On the Way to Improve Diagnostic Marker Panel for Acute Appendicitis in Adults: the Role of CalprotectinIndian Journal of Surgery 2021;  doi: 10.1007/s12262-021-03063-y
8
Vladislav Volarevic, Natasa Zdravkovic, Carl Randall Harrell, Nebojsa Arsenijevic, Crissy Fellabaum, Valentin Djonov, Miodrag L. Lukic, Bojana Simovic Markovic. Galectin-3 Regulates Indoleamine-2,3-dioxygenase-Dependent Cross-Talk between Colon-Infiltrating Dendritic Cells and T Regulatory Cells and May Represent a Valuable Biomarker for Monitoring the Progression of Ulcerative ColitisCells 2019; 8(7): 709 doi: 10.3390/cells8070709
9
Marianna Lucafò, Debora Curci, Matteo Bramuzzo, Patrizia Alvisi, Stefano Martelossi, Tania Silvestri, Veronica Guastalla, Flavio Labriola, Gabriele Stocco, Giuliana Decorti. Serum Adalimumab Levels After Induction Are Associated With Long-Term Remission in Children With Inflammatory Bowel DiseaseFrontiers in Pediatrics 2021; 9 doi: 10.3389/fped.2021.646671
10
Sylwia Fabiszewska, Edyta Derda, Edyta Szymanska, Marcin Osiecki, Jaroslaw Kierkus. Safety and Effectiveness of Vedolizumab for the Treatment of Pediatric Patients with Very Early Onset Inflammatory Bowel DiseasesJournal of Clinical Medicine 2021; 10(13): 2997 doi: 10.3390/jcm10132997
11
Amihai Rottenstreich, Tali Mishael, Sorina Grisaru Granovsky, Benjamin Koslowsky, Hagai Schweistein, Guila Abitbol, Eran Goldin, Ariella Bar-Gil Shitrit. Clinical utility of fecal calprotectin in monitoring disease activity and predicting relapse in pregnant patients with inflammatory bowel diseasesEuropean Journal of Internal Medicine 2020; 77: 105 doi: 10.1016/j.ejim.2020.03.015
12
Paulina Nuñez F, Uma Mahadevan, Rodrigo Quera, Constanza Bay, Patricio Ibañez. Treat-to-target approach in the management of inflammatory Bowel diseaseGastroenterología y Hepatología 2021; 44(4): 312 doi: 10.1016/j.gastrohep.2020.06.032
13
Dora Grgić, Karlo Golubić, Marko Brinar, Željko Krznarić. Predictive value of faecal calprotectin in ulcerative colitis – single centre experienceAnnals of Medicine 2022; 54(1): 1570 doi: 10.1080/07853890.2022.2082518
14
Dan Turner, Amanda Ricciuto, Ayanna Lewis, Ferdinando D’Amico, Jasbir Dhaliwal, Anne M. Griffiths, Dominik Bettenworth, William J. Sandborn, Bruce E. Sands, Walter Reinisch, Jürgen Schölmerich, Willem Bemelman, Silvio Danese, Jean Yves Mary, David Rubin, Jean-Frederic Colombel, Laurent Peyrin-Biroulet, Iris Dotan, Maria T. Abreu, Axel Dignass. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBDGastroenterology 2021; 160(5): 1570 doi: 10.1053/j.gastro.2020.12.031
15
Olga Maria Nardone, Uday Nagesh Shivaji, Vittoria Ferruzza, Subrata Ghosh, Marietta Iacucci. Soluble Blood Markers of Mucosal Healing in Inflammatory Bowel Disease: The Future of Noninvasive MonitoringInflammatory Bowel Diseases 2020; 26(6): 961 doi: 10.1093/ibd/izz226
16
Yoo Min Lee, Sujin Choi, Byung-Ho Choe, Hyo-Jeong Jang, Seung Kim, Hong Koh, Eun Sil Kim, Mi Jin Kim, Yon Ho Choe, Ben Kang. Association between Fecal Calprotectin and Mucosal Healing in Pediatric Patients with Crohn’s Disease Who Have Achieved Sustained Clinical Remission with Anti-Tumor Necrosis Factor AgentsGut and Liver 2022; 16(1): 62 doi: 10.5009/gnl20300
17
Steve Halligan, Darren Boone, Lucinda Archer, Tariq Ahmad, Stuart Bloom, Manuel Rodriguez-Justo, Stuart A Taylor, Sue Mallett. Prognostic biomarkers to identify patients likely to develop severe Crohn’s disease: a systematic reviewHealth Technology Assessment 2021; 25(45): 1 doi: 10.3310/hta25450
18
Lorenzo Bertani, Maria Gloria Mumolo, Gherardo Tapete, Eleonora Albano, Giovanni Baiano Svizzero, Federico Zanzi, Linda Ceccarelli, Massimo Bellini, Santino Marchi, Francesco Costa. Fecal calprotectin: current and future perspectives for inflammatory bowel disease treatmentEuropean Journal of Gastroenterology & Hepatology 2020; 32(9): 1091 doi: 10.1097/MEG.0000000000001731
19
Mariusz A. Bromke, Katarzyna Neubauer, Radosław Kempiński, Małgorzata Krzystek-Korpacka. Faecal Calprotectin in Assessment of Mucosal Healing in Adults with Inflammatory Bowel Disease: A Meta-AnalysisJournal of Clinical Medicine 2021; 10(10): 2203 doi: 10.3390/jcm10102203
20
Wan-Ting Cao, Rong Huang, Shan Liu, Yi-Hong Fan, Mao-Sheng Xu, Yi Xu, Hui Ni. Infliximab trough level combined with inflammatory biomarkers predict long-term endoscopic outcomes in Crohn’s disease under infliximab therapyWorld Journal of Gastroenterology 2022; 28(23): 2582-2596 doi: 10.3748/wjg.v28.i23.2582
21
Ziheng Peng, Jun Yi, Xiaowei Liu. A Low-FODMAP Diet Provides Benefits for Functional Gastrointestinal Symptoms but Not for Improving Stool Consistency and Mucosal Inflammation in IBD: A Systematic Review and Meta-AnalysisNutrients 2022; 14(10): 2072 doi: 10.3390/nu14102072
22
Christopher Ma, Robert Battat, Claire E. Parker, Reena Khanna, Vipul Jairath, Brian Gordon Feagan. Update on C-reactive protein and fecal calprotectin: are they accurate measures of disease activity in Crohn’s disease?Expert Review of Gastroenterology & Hepatology 2019; 13(4): 319 doi: 10.1080/17474124.2019.1563481
23
Lorenzo Bertani, Giorgia Bodini, Maria Gloria Mumolo, Nicola de Bortoli, Linda Ceccarelli, Leonardo Frazzoni, Gherardo Tapete, Eleonora Albano, Maria Corina Plaz Torres, Massimo Bellini, Edoardo Savarino, Vincenzo Savarino, Santino Marchi, Francesco Costa. Corticosteroid Treatment at Diagnosis: An Analysis of Relapses, Disease Extension, and Colectomy Rate in Ulcerative ColitisDigestive Diseases and Sciences 2020; 65(8): 2397 doi: 10.1007/s10620-019-05959-y
24
Alice Jane Foster, Matthew Smyth, Alam Lakhani, Benjamin Jung, Rollin F Brant, Kevan Jacobson. Consecutive fecal calprotectin measurements for predicting relapse in pediatric Crohn’s disease patientsWorld Journal of Gastroenterology 2019; 25(10): 1266-1277 doi: 10.3748/wjg.v25.i10.1266
25
Parul Tandon, Kristel Leung, Arif Yusuf, Vivian W. Huang. Noninvasive Methods For Assessing Inflammatory Bowel Disease Activity in PregnancyJournal of Clinical Gastroenterology 2019; 53(8): 574 doi: 10.1097/MCG.0000000000001244
26
Gionata Fiorino, Silvio Danese, Laurent Peyrin‐Biroulet, Miquel Sans, Fabrizio Bonelli, Mariella Calleri, Claudia Zierold, Roberta Pollastro, Fabio Moretti, Alberto Malesci. LIAISON ® Calprotectin for the prediction of relapse in quiescent ulcerative colitis: The EuReCa study United European Gastroenterology Journal 2022;  doi: 10.1002/ueg2.12268
27
Aleksandar Acovic, Bojana Simovic Markovic, Marina Gazdic, Aleksandar Arsenijevic, Nemanja Jovicic, Nevena Gajovic, Marina Jovanovic, Natasa Zdravkovic, Tatjana Kanjevac, C. Randall Harrell, Crissy Fellabaum, Zana Dolicanin, Valentin Djonov, Nebojsa Arsenijevic, Miodrag L. Lukic, Vladislav Volarevic. Indoleamine 2,3-dioxygenase-dependent expansion of T-regulatory cells maintains mucosal healing in ulcerative colitisTherapeutic Advances in Gastroenterology 2018; 11: 175628481879355 doi: 10.1177/1756284818793558
28
Carlijn R. Lamers, Nicole M. de Roos, Coen C. W. G. Bongers, Dominique S. M. ten Haaf, Yvonne A. W. Hartman, Ben J. M. Witteman, Maria T. E. Hopman. Repeated prolonged moderate-intensity walking exercise does not appear to have harmful effects on inflammatory markers in patients with inflammatory bowel diseaseScandinavian Journal of Gastroenterology 2021; 56(1): 30 doi: 10.1080/00365521.2020.1845791
29
Nikolas Plevris, Charlie W. Lees. Disease Monitoring in Inflammatory Bowel Disease: Evolving Principles and PossibilitiesGastroenterology 2022; 162(5): 1456 doi: 10.1053/j.gastro.2022.01.024
30
Andrew Leber, Raquel Hontecillas, Victoria Zoccoli-Rodriguez, Jean-Frederic Colombel, Jyoti Chauhan, Marion Ehrich, Nicholas Farinola, Josep Bassaganya-Riera. The Safety, Tolerability, and Pharmacokinetics Profile of BT-11, an Oral, Gut-Restricted Lanthionine Synthetase C-Like 2 Agonist Investigational New Drug for Inflammatory Bowel Disease: A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical TrialInflammatory Bowel Diseases 2019;  doi: 10.1093/ibd/izz094
31
Ruth M. Ayling, Klaartje Kok. Advances in Clinical Chemistry 2018; 87: 161 doi: 10.1016/bs.acc.2018.07.005
32
Tomer Ziv-Baran, Séamus Hussey, Malgorzata Sladek, Jorge Amil Dias, Javier Martin de Carpi, Erasmo Miele, Gabor Veres, Paolo Lionetti, Sibylle Koletzko, Federica Nuti, Anders Paerregaard, Kaija-Leena Kolho, Richard K. Russell, Ron Shaoul, Dror Weiner, Rotem Sigall Boneh, Johanna Escher, Lenne Finnby, Dan Turner, Arie Levine. Response to treatment is more important than disease severity at diagnosis for prediction of early relapse in new-onset paediatric Crohn’s diseaseAlimentary Pharmacology & Therapeutics 2018; 48(11-12): 1242 doi: 10.1111/apt.15016
33
Jun Kato, Takeichi Yoshida, Sakiko Hiraoka. Prediction of treatment outcome and relapse in inflammatory bowel diseaseExpert Review of Clinical Immunology 2019; 15(6): 667 doi: 10.1080/1744666X.2019.1593140
34
Małgorzata Krzystek-Korpacka, Radosław Kempiński, Mariusz Bromke, Katarzyna Neubauer. Biochemical Biomarkers of Mucosal Healing for Inflammatory Bowel Disease in AdultsDiagnostics 2020; 10(6): 367 doi: 10.3390/diagnostics10060367
35
Henry Taylor, Jose Ivan Serrano-Contreras, Julie A. K. McDonald, Jenny Epstein, JM Fell, Rocio C. Seoane, Jia V. Li, Julian R. Marchesi, Ailsa L. Hart. Multiomic features associated with mucosal healing and inflammation in paediatric Crohn’s diseaseAlimentary Pharmacology & Therapeutics 2020;  doi: 10.1111/apt.16086
36
Catherine R Rowan, Garret Cullen, Hugh E Mulcahy, Juliette Sheridan, Alan C Moss, Elizabeth J Ryan, Glen A Doherty. DUBLIN [Degree of Ulcerative colitis Burden of Luminal Inflammation] Score, a Simple Method to Quantify Inflammatory Burden in Ulcerative ColitisJournal of Crohn's and Colitis 2019; 13(11): 1365 doi: 10.1093/ecco-jcc/jjz067
37
Y. B. Uspenskaya, S. J. Belogubova. DIAGNOSTIC POSSIBILITIES OF FECAL CALPROTECTIN APPLICATION IN PATIENTS WITH INFLAMMATORY DOWEL DISEASES DURING PREGNANCY (literature review and clinical observations)Koloproktologia 2018; (2): 95 doi: 10.33878/2073-7556-2018-0-2-95-101
38
Monique Capron, Laurent Béghin, Céline Leclercq, Julien Labreuche, Arnaud Dendooven, Annie Standaert, Marie Delbeke, Adeline Porcherie, Maria Nachury, Arnaud Boruchowicz, Jean-Louis Dupas, Mathurin Fumery, Thierry Paupard, Sylviane Catteau, Dominique Deplanque, Jean-Frederic Colombel, Pierre Desreumaux. Safety of P28GST, a Protein Derived from a Schistosome Helminth Parasite, in Patients with Crohn’s Disease: A Pilot Study (ACROHNEM)Journal of Clinical Medicine 2019; 9(1): 41 doi: 10.3390/jcm9010041
39
Keeley M. Fairbrass, David J. Gracie, Alexander C. Ford. Relative Contribution of Disease Activity and Psychological Health to Prognosis of Inflammatory Bowel Disease During 6.5 Years of Longitudinal Follow-UpGastroenterology 2022; 163(1): 190 doi: 10.1053/j.gastro.2022.03.014
40
Amanda Ricciuto, Anne M. Griffiths. Clinical value of fecal calprotectinCritical Reviews in Clinical Laboratory Sciences 2019; 56(5): 307 doi: 10.1080/10408363.2019.1619159
41
Nobuyuki Takahashi, Chinatsu Kitazawa, Yoshitaka Itani, Yuji Awaga, Aldric Hama, Ikuo Hayashi, Hiroyuki Takamatsu. Exploratory clinical characterization of experimentally-induced ulcerative colitis nonhuman primatesHeliyon 2020; 6(1): e03178 doi: 10.1016/j.heliyon.2020.e03178
42
Monica State, Lucian Negreanu, Theodor Voiosu, Andrei Voiosu, Paul Balanescu, Radu Bogdan Mateescu. Surrogate markers of mucosal healing in inflammatory bowel disease: A systematic reviewWorld Journal of Gastroenterology 2021; 27(16): 1828-1840 doi: 10.3748/wjg.v27.i16.1828
43
Ying Cao, Yibei Dai, Lingyu Zhang, Danhua Wang, Wen Hu, Qiao Yu, Xuchu Wang, Pan Yu, Weiwei Liu, Ying Ping, Tao Sun, Yiwen Sang, Zhenping Liu, Yan Chen, Zhihua Tao. Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and CalprotectinJournal of Inflammation Research 2021; : 6409 doi: 10.2147/JIR.S342846
44
Jost Langhorst, Lana Kairey, Angela Oberle, James Boone, Gustav Dobos, Hendrik Juette, Andrea Tannapfel, Andreas Rueffer. Assessing Histological Inflammatory Activity in Patients With Ulcerative Colitis: A Diagnostic Accuracy Study Testing Fecal Biomarkers Lactoferrin and CalprotectinCrohn's & Colitis 360 2020; 2(3) doi: 10.1093/crocol/otaa053